Skip to search formSkip to main contentSkip to account menu

LB 71350

Known as: LB-71350 protease inhibitor, LB71350 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

AmidesMesylates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Solid Dispersion of an HIV Protease Inhibitor
LB71350 is an HIV protease inhibitor with poor aqueous solubility and extensive first pass effect. The purpose of the present… 
1999
1999
General Pharmacology of LB71350, a New HIV-1 Pretense Inhibitor
Safety evaluation of LB71350, a new HIV-1 protease inhibitor, was performed in mice, rats and dogs. For the general behavior of… 
1998
1998
An Irreversible HIV-1 Protease inhibitor LB71350
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)